Cite

HARVARD Citation

    Simonds, E. et al. (2021). Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. Journal for immunotherapy of cancer. 9 (6), p. . [Online]. 
  
Back to record